Radiopharm Theranostics Ltd (RADX) — Institutional Holders, Q2 2026
7 institutional investment managers reported a RADX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
RADX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- PNC FINANCIAL SERVICES GROUPAdded · +4,000 sh+$16.8K
- Integrated Wealth ConceptsNew · +1,310 sh+$5.5K
- HSBC PLCAdded · +816 sh+$3.4K
- RHUMBLINE ADVISERSAdded · +74 sh+$310.00
Biggest sellers
- SILVERARC CAPITAL MANAGEMENTSold out · -187,406 sh-$785.2K
- UBS Group AGTrimmed · -1,493 sh-$6.3K
RADX 13F holders ranked 1–7 of 7
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Stonepine Capital Management#1 · 102,000,000 sh | 102,000,000 | $794.0K | 0.37% | +100.0% |
| 2 | HSBC PLC#2 · 62,188 sh | 62,188 | $253.7K | <0.01% | +1.3% |
| 3 | Regal Partners Ltd#3 · 40,138 sh | 40,138 | $168.2K | <0.01% | 0.0% |
| 4 | PNC FINANCIAL SERVICES GROUP#4 · 20,000 sh | 20,000 | $83.8K | 0.00% | +25.0% |
| 5 | UBS Group AG#5 · 1,507 sh | 1,507 | $6.3K | 0.00% | -49.8% |
| 6 | Integrated Wealth Concepts#6 · 1,310 sh | 1,310 | $5.5K | 0.00% | New |
| 7 | RHUMBLINE ADVISERS#7 · 195 sh | 195 | $817.00 | 0.00% | +61.2% |
Funds that sold out of RADX in Q2 2026 (1)
Held RADX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| SILVERARC CAPITAL MANAGEMENT187,406 sh | 187,406 | $805.8K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.